Photodynamic Therapy (PDT): PDT Mechanisms

키워드

참고문헌 (39)

1. Dougherty TJ, "Photodynamic therapy", J Natl Cancer Inst, 90, pp.889~905 (1998)
2. Allison RR, "Clinical PD", PDT in North America: an historical review, 2004, pp.1, 263~277
3. Lipson RL, "The photodynamic properties of a particular hematoporphyrin derivative", Arch Dermatol, 82, pp.508~516 (1960)
4. Lipson RL, "Photosensitivity and heat", Arch Dermatol, 82, pp.517~520 (1960)
5. Dougherty TJ., "Photodynamic therapy (PDT) of malignant tumors", Crit Rev Oncol Hematol, 2, pp.83~116 (1984)
6. Allison RR, "Photosensitizers in clinical PDT", Photodiagnosis Photodyn Ther, 1, pp.27~42 (2004)
7. Mang TS, "Lasers and light sources for PDT: past, present and future", Photodiagnosis Photodyn Ther, 1, pp.43~48 (2004)
8. Brancaleon L, "Laser and non-laser light sources for photodynamic therapy", Lasers Med Sci, 17, pp.173~186 (2002)
9. Sibata CH, "Photodynamic therapy in oncology", Expert Opin Pharmacother, 2, pp.917~927 (2001)
10. Moan J, "The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen", Photochem Photobiol, 53, pp.549~553 (1991)
11. Mroz P, "Cell death pathways in photodynamic therapy of cancer", Cancers, 3, pp.2516~2539 (2011)
12. Oleinick NL, "The role of apoptosis in response to photodynamic therapy: what, where, why, and how", Photochem Photobiol Sci, 1, pp.1~21 (2002)
13. Igney FH, "Death and anti-death: tumour resistance to apoptosis", Nat Rev Cancer, 2, pp.277~288 (2002)
14. Boyle RW, "Structure and biodistribution relationships of photodynamic sensitizers", Photochem Photobiol, 64, pp.469~485 (1996)
15. Hamblin MR, "On the mechanism of the tumour-localising effect in photodynamic therapy", J Photochem Photobiol B, 23, pp.3~8 (1994)
16. Jori G, "The role of lipoproteins in the delivery of tumour-targeting photosensitizers", Int J Biochem, 25, pp.1369~1375 (1993)
17. Castano AP, "Mechanisms in photodynamic therapy: part three: photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction", Photodiagnosis Photodyn Ther, 2, pp.91~106 (2005)
18. Castano AP, "Mechanisms in photodynamic therapy: part two: cellular signaling, cell metabolism and modes of cell death", Photodiagnosis Photodyn Ther, 2, pp.1~23 (2005)
19. Oleinick NL, "The photobiology of photodynamic therapy: cellular targets and mechanisms", Radiat Res, 150(5 Suppl), pp.S146~S156 (1998)
20. Ding X, "Hematoporphyrin monomethyl ether photodynamic damage on HeLa cells by means of reactive oxygen species production and cytosolic free calcium concentration elevation", Cancer Lett, 216, pp.43~54 (2004)
21. Henderson BW, "Release of prostaglandin E2 from cells by photodynamic treatment in vitro", Cancer Res, 49(24 Pt 1), pp.6896~6900 (1989)
22. Henderson BW, "Effects of photodynamic treatment of platelets or endothelial cells in vitro on platelet aggregation", Photochem Photobiol, 56, pp.513~521 (1992)
23. Dahle J, "Cooperative effects of photodynamic treatment of cells in microcolonies", Proc Natl Acad Sci U S A, 94, pp.1773~1778 (1997)
24. Agarwal ML, "Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells", Cancer Res, 51, pp.5993~5996 (1991)
25. Abels C., "Targeting of the vascular system of solid tumours by photodynamic therapy (PDT)", Photochem Photobiol Sci, 3, pp.765~771 (2004)
26. Chen B, "Blood flow dynamics after photodynamic therapy with verteporfin in the RIF-1 tumor", Radiat Res, 160, pp.452~459 (2003)
27. Fingar VH, "Role of thromboxane and prostacyclin release on photodynamic therapy-induced tumor destruction", Cancer Res, 50, pp.2599~2603 (1990)
28. McMahon KS, "Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response", Cancer Res, 54, pp.5374~5379 (1994)
29. Krosl G, "Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG)", Cancer Lett, 84, pp.43~49 (1994)
30. Gollnick SO, "Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo", Cancer Res, 57, pp.3904~3909 (1997)
31. Coutier S, "Foscan (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-alpha-mediated cytolytic activity", Br J Cancer, 81, pp.37~42 (1999)
32. Gollnick SO, "Role of cytokines in photodynamic therapy-induced local and systemic inflammation", Br J Cancer, 88, pp.1772~1779 (2003)
33. Allison RR, "Photofrin photodynamic therapy: 2.0 mg", kg or not 2.0 mg, Photodiagnosis Photodyn Ther, pp.2008, 5[DOI]
34. Allison RR, "Photodiagnosis for cutaneous malignancy: a brief clinical and technical review", Photodiagnosis Photodyn Ther, 5, pp.247~250 (2008)
35. Hamblin MR, "In vivo fluorescence imaging of the transport of charged chlorin e6 conjugates in a rat orthotopic prostate tumour", Br J Cancer, 81, pp.261~268 (1999)
36. Kurohane K, "Photodynamic therapy targeted to tumor-induced angiogenic vessels", Cancer Lett, 167, pp.49~56 (2001)
37. Chen B, "Antivascular tumor eradication by hypericin-mediated photodynamic therapy", Photochem Photobiol, 76, pp.509~513 (2002)
38. Allison RR, "Future PDT", Photodiagnosis Photodyn Ther, 6, pp.231~234 (2009)
39. Allison RR, "Future of oncologic photodynamic therapy", Future Oncol, 6, pp.929~940 (2010)

관련 논문AI추천